KURA icon

Kura Oncology
KURA

Overview Fund Activity

76 hedge funds and large institutions have $299M invested in Kura Oncology in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.73%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
26
Reduced
23
Closed
6
Calls
$5K
Puts
$2K
Net Calls
+$3K
Net Calls Change
+$3K

Top Buyers

1
BlackRock
1
BlackRock
New York
$23.3M
2
GPP
2
Great Point Partners
Connecticut
$33.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$3.66M
4
NC
4
Nexthera Capital
New York
$6.82M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$2.65M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$26.8M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$31.8M
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$150K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.37M
5
Deutsche Bank
5
Deutsche Bank
Germany
$819K
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
76
Avior Wealth Management
Nebraska
$1K – – –
IHM
77
Iguana Healthcare Management
New York
– -$1.35M -90,000 Closed
VF
78
Virtu Financial
New York
– -$1.03M -68,658 Closed
NFA
79
Nationwide Fund Advisors
Ohio
– -$643K -42,981 Closed
EMG
80
Ellington Management Group
Connecticut
– -$212K -14,200 Closed
CS
81
Credit Suisse
Switzerland
– -$190K -12,761 Closed
TRCT
82
Tower Research Capital (TRC)
New York
– -$2K -136 Closed
1 2 3
4